GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Panacos Pharmaceuticals, Inc. (PANC) [hlAlert]

Rating:
Outperform
PANC
down 99.94 %

Panacos Pharmaceuticals, Inc. (PANC) rated Outperform by Bear Stearns

Posted on: Wednesday,  Mar 5, 2008  8:25 AM ET by Bear Stearns

Bear Stearns rated Outperform Panacos Pharmaceuticals, Inc. (OTCBB: PANC) on 03/05/2008, when the stock price was $0.90. Since
then, Panacos Pharmaceuticals, Inc. has lost 99.94% as of 08/07/2015's recent price of $0.00.
If you would have followed this Bear Stearns's recommendation on PANC, you would have lost 99.94% of your investment in 2711 days.

Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

The Bear Stearns Companies Inc. (NYSE: BSC) is the parent company of Bear, Stearns & Co. Inc., a leading global investment banking, securities trading and brokerage firm. Since 1923, we have helped corporations, institutions, governments and individuals reach their financial objectives. Clients have come to rely on the breadth of our expertise, our commitment to client service and our innovative approach to problem-solving. Talented professionals join Bear Stearns because of our unique corporate culture. Based on respect, integrity, meritocracy, innovation and a commitment to philanthropy, these guiding principles serve as blueprint for the way that we do business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/5/2008 8:25 AM Buy
None
0.90
as of 12/24/2008
1 Week up  300.00 %
1 Month down  -33.33 %
3 Months down  -42.85 %
1 YTD down  -71.42 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy